Oct 19, 2012, 06:00 AM by Michael Croft

Bio-IT World Guest Column | The Skeptical Outsider | Few perks of wealth are more widely demonized than the private jet. Yet these very symbols of power and luxury could save health care dollars by being placed at the disposal of the poor. In what alternate universe is this possible, you ask? In today’s Rube Goldberg U.S. health care market, where else?

Oct 18, 2012, 10:00 AM by Michael Croft

Technology Review | The race to Mars is on! J. Craig Venter and Jonathan Rothberg both have their sights set on sequencing DNA found on the red planet.

Oct 18, 2012, 09:00 AM by Michael Croft

CA Technologies | A CA Technologies survey finds that more than 80% of IT decision makers call the mainframe a "highly strategic part of their IT plans." But  most consider it essential within the realm of their cloud plans.

Oct 18, 2012, 09:00 AM by Michael Croft

Extreme Tech | George Church and colleague Sri Kosuri at Harvard have successfully stored 5.5 petabits of data — around 700 terabytes — in a single gram of DNA using the DNA as just another digital storage device.

Oct 18, 2012, 09:00 AM by Michael Croft

Scalyr Blog | Scalyr Blog breaks down Amazon's EC2 I/O performance with data from over 1,000 EC2 instances, $1,000 in AWS charges and billions of I/O operations. The results were stranger than they expected.

Oct 17, 2012, 14:00 PM by Michael Croft

NYGC | There are two opinions in sequencing: "bigger is better" and "small is best." Big sequencing centers can scale efficiently, but sometimes big centers can't meet the specific needs of users.

Oct 17, 2012, 10:00 AM by Michael Croft

Wired | A peek into Google's top secret data center featuring a Google Street View tour and more.

Oct 17, 2012, 09:00 AM by Michael Croft

Forbes | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price.

Oct 16, 2012, 07:00 AM by Michael Croft

Oct 15, 2012, 14:00 PM by Michael Croft

Washington Business Journal | A new comprehensive cancer center planned for Northern Virginia might be able to accomplish what Dietrich Stephan's Ignite Institue wasn't able to.

Oct 15, 2012, 08:00 AM by Michael Croft

Bloomberg | AstraZeneca has partnered with Beijing-based Pharmaron to expand their R&D efforts. The partnership adds "a few hundred" researchers to AstraZeneca's team in China.

Oct 15, 2012, 08:00 AM by Michael Croft

Oct 12, 2012, 14:00 PM by Michael Croft

Nature News Blog | Mount Sinai Medical School in New York is offering an elective course called ‘Practical Analysis of Your Personal Genome’ this year. The goal is to teach upcoming physicians how sequencing information might affect clinical care.

Oct 12, 2012, 09:00 AM by Michael Croft

Oct 11, 2012, 10:00 AM by Michael Croft

PM Live | GlaxoSmithKline has released access to 200 compounds with possible action against tuberculosis in a move toward an "open innovation" approach to R&D.

Oct 11, 2012, 09:00 AM by Michael Croft

Forbes | The FDA took a generic version of Wellbutrin XL off the market yesterday because it just doesn't work--and hasn't worked for years.

Oct 10, 2012, 12:00 PM by Michael Croft

Oct 10, 2012, 09:00 AM by Michael Croft

Bio-IT World Roundup | The Nobel Prize in chemistry was awarded to two doctors for their work with G-protein-coupled receptors.

Oct 10, 2012, 08:00 AM by Michael Croft

Nature News | A paper slated to appear in the American Economic Review claims that a country's genetic diversity can predict the success of its economy. Critics worry that the paper is making claims that the inverse is also true.

Oct 9, 2012, 11:00 AM by Michael Croft

The Guardian | With the announcement of the Nobel Prize in physics, The Guardian looks at the pros and cons of scientific awards as rewards or as incentives.